Is metformin indicated as primary ovulation induction agent in women with PCOS? A systematic review and meta-analysis

Gynecologic and Obstetric Investigation

Volumn 73, Issue 4, 2012, Pages 304-313

  Siebert, T I ^a   Viola, M I ^a   Steyn, D W ^a   Kruger, T F ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

Clomiphene citrate; Metformin; Ovulation induction; Polycystic ovarian syndrome; Randomized controlled trials

Indexed keywords

CLOMIFENE CITRATE; METFORMIN;

ARTICLE; BIRTH RATE; DRUG EFFICACY; DRUG INDICATION; HUMAN; LIVE BIRTH; META ANALYSIS; OUTCOME ASSESSMENT; OVARY POLYCYSTIC DISEASE; OVULATION; OVULATION INDUCTION; PREGNANCY RATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; TREATMENT OUTCOME;

CLOMIPHENE; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INFERTILITY, FEMALE; LIVE BIRTH; METFORMIN; OVULATION INDUCTION; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84862488675     PISSN: 03787346     EISSN: 1423002X     Source Type: Journal    
DOI: 10.1159/000335253     Document Type: Article

References (46)

1. Polson DW, Adams J, Wadsworth J, Franks S: Polycystic ovaries - a common finding in normal women. Lancet 1998; 1: 870-872.
2. The Rotterdam ESHRE/ASRM sponsored PCOS consensus group: Revised 2003 consensus on diagnostic criteria and long-term health risk related to polycystic ovary syndrome. Hum Reprod 2004; 19: 41-47.
3. Chang RJ, Nakamura RM, Judd HL, Kaplan SA: Insulin resistance in non-obese patients with polycystic ovarian disease. J Clin Endocrinol Metab 1983; 57: 356-359. (Pubitemid 13032489)
4. Dunaif A: Insulin resistance and the polycystic ovarian syndrome: mechanism and implications for pathogenesis. Endocrinol Rev 1997; 18: 774-800.
5. Burghen GA, Givens JR, Kitabchi AE: Correlation of hyperandrogenism with hyperinsulinemia in polycystic ovarian disease. J Clin Endocrinol Metab 1980; 50: 113-115.
6. Velazquez EM, Mendoza SG, Hamer T, Sosa F, Glueck CJ: Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenaemia and systolic blood pressure, while facilitating normal menses and pregnancy. Metabolism 1994; 43: 647-654. (Pubitemid 24145474)
7. Kashyap S, Wells GA, Rosenwaks Z: Insulin-sensitizing agents as primary therapy for patients with polycystic ovarian syndrome. Hum Reprod 2004; 19: 2474-2483. (Pubitemid 39481270)
8. Erhmann D, Schneider DJ, Sobel BE, Cavaghan MK, Imperial J, Sturis J et al: Troglitazone improves defects in insulin action, insulin secretion, ovarian steroid genesis, and fibrinolysis in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1997; 82: 2108-2116. (Pubitemid 27287569)
9. Nestler JE, Jakubowicz D: Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17 α activity and serum androgens. J Clin Endocrinol Metab 1997; 82: 4075-4079. (Pubitemid 27525516)
10. Nestler JE, Jakubowicz DJ, Evans WS, Pasquali R: Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N Engl J Med 1998; 338: 1876-1880. (Pubitemid 28287859)
11. Practice Committee of the American Society for Reproductive Medicine: Use of insulin-sensitizing agents in the treatment of polycystic ovary syndrome. Fertil Steril 2008; 90:S69-S73.
12. Shepard MK, Balmaceda JP, Leija CG: Relationship of weight to successful induction of ovulation with clomiphene citrate. Fertil Steril 1979; 32: 641-645.
13. O'Herlihy C, Pepperell RJ, Brown JB, Smith MA, Sandri L, McBain JC: Incremental clomiphene therapy: a new method of treating persistent anovulation. Obstet Gynaecol 1981; 58: 535-542.
14. Lobo RA, Gysler M, March CM, Goebelsmann U, Mishell DR Jr: Clinical and laboratory predictors or clomiphene response. Fertil Steril 1982; 37: 168-174. (Pubitemid 12171167)
15. Siebert IT, Kruger TF, Steyn DW, Nosarka S: Is the addition of metformin efficacious in the treatment of clomiphene citrate-resistant patients with polycystic ovary syndrome? A structured literature review. Fertil Steril 2006; 86: 1432-1437. (Pubitemid 44602073)
16. Costello MF, Eden JA: A systematic review of the reproductive system effects of metformin in patients with polycystic ovary syndrome. Fertil Steril 2003; 79: 1-13. (Pubitemid 36071228)
17. Palomba S, Pasquali R, Orio Jr F, Nestler JE: Clomiphene citrate, metformin or both as first-step approach in treating anovulatory infertility in patients with polycystic ovary syndrome: a systematic review of head-to-head randomized controlled studies and meta-analysis. Clin Endocrinol 2009; 70: 311-321.
18. Moll E, Van der Veen F, van Wely M: The role of metformin in polycystic ovary syndrome: a systematic review. Hum Reprod 2007; 13: 527-537.
19. Moll M, Bossuyt PMM, Korevaar JC, Lambalk CB, Van der Veen F: Effect of clomiphene citrate plus metformin and clomiphene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double-blind clinical trial. BMJ 2006; 332: 1485-1489.
20. Legro RS, Barnhart HX, Schlaff WD, Carr BR, Diamond MP, Carson SA, et al: Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med 2007; 356: 551-566. (Pubitemid 46220816)
21. Neveu N, Granger L, St-Michel P, Lavoie HB: Comparison of clomiphene citrate, metformin, or the combination of both for first-line ovulation induction and achievement of pregnancy in 154 women with polycystic ovary syndrome. Fertil Steril 2007; 87: 113-120. (Pubitemid 46013871)
22. Siebert TI, Kruger TF, Lombard CJ: Evaluating the equivalence of clomiphene citrate with and without metformin in ovulation induction in PCOS patients. J Assist Reprod Genet 2009; 26: 165-171.
23. Palomba S, Orio F, Falbo A, Manguso F, Russo T, Cascella T, et al: Prospective parallel randomised, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in non-obese anovulatory women with polycystic ovary syndrome. J Clin End Metab 2005; 90: 4068-4074. (Pubitemid 41058174)
24. Zain MM, Jamaluddin R, Ibrahim A, Norman RJ: Comparison of clomiphene citrate, metformin, or the combination of both for first-line ovulation induction, achievement of pregnancy, and live birth in Asian women with polycystic ovary syndrome: a randomized controlled trial. Fertil Steril 2009; 91: 514-521.
25. Singh I, Bedaiwy MA, Hatwal A, Kumar A, Agarwal A: Increased pregnancy rates with metformin and clomiphene citrate in non-obese patients with polycystic ovary syndrome: prospective randomised study. Fertil Steril 2001; 73:S94.
26. Johnson NP, Stewart AW, Falkiner J, Farquhar CM, Milsom S, Singh VP, Okonkwo QL, Buckingham KL: PCOSMIC: A multi-centre randomized trial in women with polycystic ovary syndrome evaluating metformin for infertility with clomiphene. Hum Reprod 2010; 25: 1675-1683.
27. Karimzadeh MA, Javedani M: An assessment of lifestyle modification versus medical treatment with clomiphene citrate, metformin, and clomiphene citrate-metformin in patients with polycystic ovary syndrome. Fertil Steril 2010; 94: 216-220.
28. Khorram O, Helliwell JP, Katz S, Bompane CM, Jaramillo L: Two weeks of metformin improves clomiphene citrate-induced ovulation and metabolic profiles in women with polycystic ovary syndrome. Fertil Steril 2006; 85: 1448-1451.
29. Sahin Y, Yirmibes U, Kalestimur F, Aygen E: The effects of metformin on insulin resistance, clomiphene-induced ovulation and pregnancy rates in women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 2004; 113: 214-220. (Pubitemid 38456778)
30. El-Biely MM, Habba M: The use of metformin to augment the induction of ovulation in obese infertile patients with polycystic ovary syndrome. Middle East Fertil Soc J 2001; 6: 43-49. (Pubitemid 32489075)
31. Ben Ayed B, Dammak dit Mlik S, Ben Arab H, Chahtour H, Mathlouthi N, Dhuib M, Kassi M, Saiidane D, Trabelssi K, Guermazi M: Metformin effects on clomiphene-induced ovulation in the polycystic ovary syndrome. Tun Med 2009; 87: 43-49.
32. Dasari P, Pranahita GK: The efficacy of metformin and clomiphene citrate combination compared with clomiphene citrate alone for ovulation induction in infertile patients with PCOS. J Hum Reprod Sci 2009; 2: 18-22.
33. Moll E, Korevaar JC, Bossuyt PMM, Van der Veen F: Does adding metformin to clomiphene citrate lead to higher pregnancy rates in a subset of women with polycystic ovary syndrome? Hum Reprod 2008; 23: 1830-1834. (Pubitemid 352020013)
34. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. Diabetes Prevention Program Research Group. N Engl J Med 2002; 346: 393-403. (Pubitemid 34437694)
35. Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, et al: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. Finnish Diabetes Prevention Study Group. N Engl J Med 2001; 344: 1343-1350. (Pubitemid 32378388)
36. Arslanian SA, Lewy V, Danadian K, Saad R: Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance. J Clin Endocrinol Metab 2002; 87: 1555-1559. (Pubitemid 34615238)
37. Unlühizarci K, Keleştimur F, Bayram F, Sahin Y, Tutuş A: The effects of metformin on insulin resistance and ovarian steroidogenesis in women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 1999; 51: 231-236.
38. Lord JM, Flight IH, Norman RJ: Metformin in polycystic ovary syndrome: systematic review and meta-analysis. BMJ 2003; 327: 951-953.
39. Clark AM, Ledger W, Galletly C, Tomlinson L, Blaney F, Wang X, Norman RJ: Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women. Hum Reprod 1995; 10: 2705-2712.
40. Crosignani PG, Colombo M, Begetti W, Somigliana E, Gessati A, Ragni G: Overweight and obese anovulatory patients with polycystic ovaries: parallel improvements in anthropomorphic indices, ovarian physiology and fertility rate induced by diet. Hum Reprod 2003; 18: 1928-1932. (Pubitemid 37107570)
41. Tso LO, Costello MF, Andriolo RB, Freitas V: Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome. Cochrane Database Syst Rev 2009(2):CD006105.
42. Kjotrod SB, Von During V, Carlsen SM: Metformin treatment before IVF/ICSI in women with polycystic ovary syndrome; a prospective, randomized, double-blind study. Hum Reprod 2004; 6: 1315-1322. (Pubitemid 38807702)
43. Onalan G, Pabuccu R, Goktolga U, et al: Metformin treatment in patients with polycystic ovary syndrome undergoing in vitro fertilization: a prospective randomized trial. Fertil Steril 2005; 4: 798-801. (Pubitemid 41317755)
44. Tang T, Glanville J, Orsi N, Barth JH, Balen AH: The use of metformin for women with PCOS undergoing IVF treatment. Hum Reprod 2006; 6: 1416-1425. (Pubitemid 44445016)
45. Metformin Official FDA Information: Side effects and use. www.drugs.com/sfx/metformin-side-effects.html.
46. Tang T, Lord JM, Norman RJ, Yasmin E, Balen AH: Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiroinositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev 2010(1): CD003053.